Ascend Wellness Holdings (AAWH) Other Working Capital Changes (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Other Working Capital Changes came in at -$635000.0 in Q1 2026, up 37.0% year-on-year from -$463490.2 in Q1 2025, and up 15.11% quarter-over-quarter from -$748000.0 in Q4 2025.
Ascend Wellness Holdings (AAWH) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$635000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 37.0% year-over-year to -$635000.0 in Q1 2026; TTM through Mar 2026 was -$3.1 million, a 0.99% decrease from a year earlier, with the FY2025 full-year figure at -$3.4 million, down 38.81% from the prior year.
- Other Working Capital Changes grew to -$635000.0 in Q1 2026 per AAWH's latest filing, from -$748000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $9.1 million in Q2 2023 and bottomed at -$3.4 million in Q4 2022.
- The 5-year median for Other Working Capital Changes is -$45000.0 (2024), against an average of $247470.6.
- Across the five-year window, Other Working Capital Changes jumped 5096.0% in 2022 and sank 1096.36% in 2024, its largest moves.
- Year by year, Other Working Capital Changes stood at -$37000.0 in 2022, then sank by 205.41% to -$113000.0 in 2023, then slumped by 523.01% to -$704000.0 in 2024, then declined by 6.25% to -$748000.0 in 2025, then rose by 15.11% to -$635000.0 in 2026.
- Per Business Quant, the three latest AAWH Other Working Capital Changes figures stand at -$635000.0 (Q1 2026), -$748000.0 (Q4 2025), and -$772000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Ascend Wellness Holdings | 77.94 Mn | 17.02 Mn | 44.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 641,000.00 |
| Mar 31, 2026 | 641,000.00 |
| Mar 31, 2026 | 641,000.00 |
| Dec 31, 2025 | 2.65 Mn |
| Dec 31, 2025 | 2.65 Mn |
| Dec 31, 2025 | 2.65 Mn |
| Sep 30, 2025 | -3.13 Mn |
| Sep 30, 2025 | -3.13 Mn |
| Sep 30, 2025 | -3.13 Mn |
| Jun 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | 2.43 Mn |
| Mar 31, 2025 | 379,000.00 |
| Mar 31, 2025 | 379,000.00 |
| Mar 31, 2025 | 379,000.00 |
| Dec 31, 2024 | 811,000.00 |
| Dec 31, 2024 | 811,000.00 |
| Dec 31, 2024 | 811,000.00 |
| Sep 30, 2024 | -45,000.00 |
| Sep 30, 2024 | -45,000.00 |